Healthcare Professional Access Required

You are attempting to access professional medical device information intended exclusively for healthcare professionals.

⚠️ Important Notice: This information is not intended for members of the general public. By proceeding, you confirm that you are a registered healthcare professional or are accessing this information in a professional capacity.

I confirm that I am a healthcare professional (doctor, nurse, allied health professional, or other qualified healthcare worker) and wish to access professional medical device information.

A structured perspective on exposure in endoscopy

Near-Field Exposure Considerations in Endoscopic Procedures

Exposure begins at the patient interface. Many established controls operate after release.

Established measures, including personal protective equipment (PPE), ventilation, and airborne precautions (supported by appropriate room design where applicable), are recognised to reduce exposure risk.

Near-Field Exposure Mitigation is presented as a conceptual framework to support structured consideration of exposure at the point of patient interface, and how an upstream, procedure-level control layer may complement existing measures within a broader hierarchy of controls.

Understand the Framework Browse Products Discuss Clinical Fit

Important Information
The information presented on this website is intended for healthcare professionals and is provided for general educational and informational purposes only.

It is not intended to represent clinical advice, regulatory guidance, or to make claims regarding the performance of any specific medical device.

Users should refer to the manufacturer’s Instructions for Use and Australian sponsor information for device-specific indications, limitations, and safety information.

The NEMF Framework

Near-Field Exposure Mitigation introduces an upstream control layer at the patient interface, complementing PPE, ventilation, and existing infection prevention controls within endoscopic procedures.

At the source Patient interface mitigation

Acts closer to release, where unmanaged near-field exposure begins.

At the room level Ventilation and AII

Remain important for dilution, containment, and environmental control.

At the worker level PPE remains essential

Supports residual protection and remains part of the layered control model.

Near-Field Exposure Mitigation is presented as an adjunct framework-based layer. It does not replace PPE, ventilation, AII, or broader infection prevention and control measures.

Why Choose CliniSalus?

🛡️

Infection Prevention and Control Focus

Specialised products designed specifically for Infection Prevention and Control, addressing critical safety gaps in healthcare settings.

✓

Quality Assured

Every product undergoes rigorous testing to ensure compliance with Australian standards and regulatory requirements.

🔬

Innovation Driven

Bringing new and innovative solutions from the global market that are specifically suitable for Australian healthcare environments.

About CliniSalus

CliniSalus is an emerging Australian-based medical device distributor with distribution across Australia and New Zealand, dedicated to addressing critical product gaps in patient and clinician safety through advanced Infection Prevention and Control solutions.

Our foundation is built on a commitment to sourcing evidence-based, innovative medical devices and consumables from global manufacturers and delivering them to healthcare professionals across Australia and New Zealand. We focus exclusively on products that demonstrate measurable improvements in infection prevention and control, supporting both patient safety and clinician protection.

As a start-up enterprise, we have deliberately commenced operations with a carefully selected range of products, each chosen for its clinical efficacy, regulatory compliance, and suitability for local healthcare environments. This focused approach allows us to maintain rigorous quality standards while building strong relationships with healthcare providers.

Our growth strategy centres on continuous market assessment and engagement with healthcare professionals to identify emerging needs in Infection Prevention and Control. As we expand our product portfolio, we remain committed to the principles that define CliniSalus: clinical excellence, regulatory alignment, and a sustained commitment to safety outcomes.